Molten Ventures (GB:GROW) has released an update.
Molten Ventures has successfully closed the sale of medical technology company Endomag to Hologic, Inc, with transaction proceeds surpassing their holding value, leading to a significant return on investment. In line with its capital allocation strategy, the firm has initiated a £10 million share buyback program and secured a new £180 million debt facility to replace the existing one, aiming to strengthen its financial structure for future investments.
For further insights into GB:GROW stock, check out TipRanks’ Stock Analysis page.
